Last reviewed · How we verify

Rosuvastatin or atorvastatin or simvastatin and clopidogrel

AstraZeneca · FDA-approved active Small molecule Quality 0/100

Rosuvastatin or atorvastatin or simvastatin and clopidogrel is a Small molecule drug developed by AstraZeneca. It is currently FDA-approved. Also known as: Crestor.

Rosuvastatin, atorvastatin, or simvastatin in combination with clopidogrel, marketed by AstraZeneca, holds a significant position in the cardiovascular drug market. The key composition patent expires in 2028, providing a strong competitive advantage until then. The primary risk is the potential increase in generic competition post-patent expiry.

At a glance

Generic nameRosuvastatin or atorvastatin or simvastatin and clopidogrel
Also known asCrestor
SponsorAstraZeneca
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Rosuvastatin or atorvastatin or simvastatin and clopidogrel

What is Rosuvastatin or atorvastatin or simvastatin and clopidogrel?

Rosuvastatin or atorvastatin or simvastatin and clopidogrel is a Small molecule drug developed by AstraZeneca.

Who makes Rosuvastatin or atorvastatin or simvastatin and clopidogrel?

Rosuvastatin or atorvastatin or simvastatin and clopidogrel is developed and marketed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).

Is Rosuvastatin or atorvastatin or simvastatin and clopidogrel also known as anything else?

Rosuvastatin or atorvastatin or simvastatin and clopidogrel is also known as Crestor.

What development phase is Rosuvastatin or atorvastatin or simvastatin and clopidogrel in?

Rosuvastatin or atorvastatin or simvastatin and clopidogrel is FDA-approved (marketed).

Related